2010
DOI: 10.1016/j.leukres.2009.08.037
|View full text |Cite
|
Sign up to set email alerts
|

NDRG1/2 expression is inhibited in primary acute myeloid leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
30
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 21 publications
2
30
0
Order By: Relevance
“…As a downstream regulated gene of Myc, it has been confirmed that the expression of NDRG2 was reduced in many types of tumors. Our previous data and other reports showed that NDRG2 expression was decreased in a variety of malignancy such as breast cancer, lung cancer, hepatocellular cancer, glioma, oral squamous cell carcinoma, thyroid cancer, and myeloid leukemia, which suggested that it might serve as an important role in the modulation of the aggressive behavior of malignant tumor progression (7)(8)(9)(10)(11)(12)(13)(14)(15)(16). We have previously shown that NDRG2 expression was significantly decreased in colorectal cancer (CRC) and associated with tumor differentiation status by real-time PCR, Western blot, and immunohistochemical assay (14,17).…”
Section: Introductionmentioning
confidence: 75%
“…As a downstream regulated gene of Myc, it has been confirmed that the expression of NDRG2 was reduced in many types of tumors. Our previous data and other reports showed that NDRG2 expression was decreased in a variety of malignancy such as breast cancer, lung cancer, hepatocellular cancer, glioma, oral squamous cell carcinoma, thyroid cancer, and myeloid leukemia, which suggested that it might serve as an important role in the modulation of the aggressive behavior of malignant tumor progression (7)(8)(9)(10)(11)(12)(13)(14)(15)(16). We have previously shown that NDRG2 expression was significantly decreased in colorectal cancer (CRC) and associated with tumor differentiation status by real-time PCR, Western blot, and immunohistochemical assay (14,17).…”
Section: Introductionmentioning
confidence: 75%
“…For example, NDRG1 is identified as a tumor suppressor-its expression could reduce the invasion and metastasis of breast, colon, prostate, and pancreatic cancers by modulating proliferation, differentiation, and angiogenesis of cancer cells (Kehlen et al, 2003;Kovacevic et al, 2008;Liu et al, 2011;Malette et al, 2003;Tschan et al, 2010). NDRG2 is also described as a tumor suppressor.…”
Section: Discussionmentioning
confidence: 99%
“…Gene expression assays for ATG2A, ATG2B, and ATG14L used in a 96-well format on the StepOnePlus Sequence detection system were Hs00390076_m1, Hs00216083_m1, and Hs00208732_m1, respectively (Life Technologies, Zug, Switzerland). Hydroxymethylbilane synthase (HMBS) primers and probes have been described previously ( 54 ), and data analysis was performed as described ( 55 ).…”
Section: Quantitative Real-time Rt-pcrmentioning
confidence: 99%